APA (7th ed.) Citation

Guo, T., Wu, C., Zhou, L., Zhang, J., Wang, W., Shen, Y., . . . Liu, X. (2023). Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment. Journal of Translational Medicine, 21(1), 1. https://doi.org/10.1186/s12967-023-04332-y

Chicago Style (17th ed.) Citation

Guo, Tongxuan, et al. "Preclinical Evaluation of Mito-LND, a Targeting Mitochondrial Metabolism Inhibitor, for Glioblastoma Treatment." Journal of Translational Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12967-023-04332-y.

MLA (9th ed.) Citation

Guo, Tongxuan, et al. "Preclinical Evaluation of Mito-LND, a Targeting Mitochondrial Metabolism Inhibitor, for Glioblastoma Treatment." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12967-023-04332-y.